ORCID
- David A. Sheridan: 0000-0001-5100-814X
DOI Link
Publication Date
2022-03-30
Publication Title
Journal of Hepatology
ISSN
0168-8278
Acceptance Date
2022-02-28
Deposit Date
2022-04-22
Embargo Period
2022-04-23
Recommended Citation
Bowlus, C., Galambos, M., Aspinall, R., Hirschfield, G., Jones, D., Dörffel, Y., Gordon, S., Harrison, S., Kremer, A., Mayo, M., Thuluvath, P., Levy, C., Swain, M., Neff, G., Sheridan, D., Stanca, C., Berg, C., Goel, A., Shiffman, M., Vierling, J., Boudes, P., Steinberg, A., Choi, Y., & McWherter, C. (2022) 'A phase II, randomized, open-label, 52-week study of seladelpar in patients with primary biliary cholangitis', Journal of Hepatology, . Available at: 10.1016/j.jhep.2022.02.033
